v3 Template
J

Jubilant HollisterStier

Pharmaceuticals ~40 employees
Founded
--
Employees (Est.)
~40
4 leaders known
Total Funding
$23.8M
Funding Rounds
1
Last Funding
2023-03-16

About Jubilant HollisterStier

Jubilant Pharma is a global pharmaceutical company focused on developing and producing pharmaceuticals, providing manufacturing services, and specializing in areas like nuclear medicine and allergy treatment. With a heritage of innovation and quality, they aim to improve lives through their products and services, operating as a fully integrated entity with a presence in multiple regions.

Products & Services

Radiopharma:Specializes in nuclear medicine, combining clinical expertise with a leading pharmacy network to advance the practice of nuclear medicine.
Allergy Therapy Products:Offers over 200 allergenic extracts and standard allergy vaccine mixtures for the allergy specialty industry.
Contract Manufacturing:Manufactures parenteral products, ophthalmics, ointments, creams, and gels at two facilities in North America.
Generics:Focuses on the manufacture and sale of finished dosage formulations for CVS, CNS, GI, and anti-allergy therapeutic categories.
APIs:Produces Active Pharmaceutical Ingredients approved by top global regulatory bodies, serving as a preferred partner for innovator and generic pharmaceutical companies.

Specialties

Nuclear Medicine Allergy Immunotherapy Contract Manufacturing Generics Active Pharmaceutical Ingredients (APIs)

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Grant
T: -
FT: Grant
A: 23800000
MR: -
FA: 23.8 million
FAN: 23800000
D: 2023-03-16
FD: 2023-03-16
2 investors
Grant Latest
2023-03-16
$23.8M
2 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

S

Shyam S Bhartia

Chairman & Managing Director

C

Chris Preti

CEO - CDMO

K

Kevin Fortier

Chief Commercial Officer, US Generics Business

M

Mary Coleman

VP and Head, Investor Relations

View 1 more team members with Pro

Unlock Full Team Directory

Recent News

Jubilant HollisterStier Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Pharmaceuticals
Company Size
~40 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro